Cargando…
Comparison of the long-term efficacy between entecavir and tenofovir in treatment- naïve chronic hepatitis B patients
BACKGROUND: There have been limited studies directly comparing the long-term efficacy between entecavir (ETV) and tenofovir disoproxil fumarate (TDF). This study was aimed to compare the long-term efficacy between them in treatment-naïve chronic hepatitis B (CHB). METHODS: Out of 345 CHB patients wh...
Autores principales: | Park, Ji Won, Kwak, Kyeong Min, Kim, Sung Eun, Jang, Myoung Kuk, Suk, Ki Tae, Kim, Dong Joon, Park, Sang Hoon, Lee, Myung Seok, Kim, Hyoung Su, Park, Choong Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345200/ https://www.ncbi.nlm.nih.gov/pubmed/28279168 http://dx.doi.org/10.1186/s12876-017-0596-7 |
Ejemplares similares
-
Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naïve Chronic Hepatitis B patients
por: Yu, Hyung Min, et al.
Publicado: (2015) -
Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B
por: Kim, Young Min, et al.
Publicado: (2018) -
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
por: Woo, Hyun Young, et al.
Publicado: (2020) -
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019) -
Portal hypertensive gastropathy as a prognostic index in patients with liver cirrhosis
por: Bang, Chang Seok, et al.
Publicado: (2016)